# Risk Capital Partners buys majority stake in Xstrahl

Risk Capital Partners acquired a majority stake in Xstrahl, a medical devices company that designs and manufactures X-ray systems for cancer treatment and research.

- Type: Acquisition
- Announced: 2018-03-12
- Where: Britain, United Kingdom
- Status: announced
- Products: superficial orthovoltage X-ray systems, pre-clinical X-ray systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Risk Capital Partners](https://endata.com/companies/30693.md) (acquirer)
- [Xstrahl](https://endata.com/companies/30694.md) (target)

## Sources

- [riskcapitalpartners.co.uk](https://riskcapitalpartners.co.uk/2018/03/12/1560/), 2018-03-12: "Risk Capital Partners, today announces that it has bought a majority stake in Xstrahl, a medical devices business that designs and delivers effective clinical and research solutions to advance radiation oncology."
- [xstrahl.com](https://xstrahl.com/risk-capital-partners-backs-xstrahl-buyout/), 2018-04-05: "Risk Capital Partners, the private equity firm chaired by Luke Johnson, today announces that it has bought a majority stake in Xstrahl."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.